FILSPARI was developed by Travere Therapeutics and has been granted Orphan Drug Designation for the treatment of IgA nephropathy in the UK, Europe and the U.S. FILSPARI is currently available in the U ...

ST. GALLEN, Switzerland — A Unesco (United Nations Educational, Scientific and Cultural Organization) World Heritage site, ...

Due to the death of Pope Francis, the election of the bishop of St. Gallen has been postponed for the time being. The ...

Sportradar Group AG (Nasdaq: SRAD) (“Sportradar” or the “Company”) today announced the pricing of the previously announced ...

Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Enrico Maaßen Formation: 3 - 4 - 3 Manager: Didier Tholot Formation ...

A new research project at the University of St.Gallen, funded by the Swiss National Science Foundation, will investigate how changes in aviation ...

Sportradar Group AG (Nasdaq: SRAD) (“Sportradar” or the “Company”) today announced a proposed secondary public offering of an aggregate of 23,000,000 ...

Sportradar Group AG (Nasdaq: SRAD) (“Sportradar” or the “Company”) today announced the pricing of the previously announced secondary public offering of an aggregate of 23,000,000 Class A ordinary ...

Sportradar Group AG (Nasdaq: SRAD) (“Sportradar” or the “Company”) today announced a proposed secondary public offering of an aggregate of 23,000,000 ...